Breast Cancer Special Issue 2019

New Drug Pipeline for HER2-Positive Treatment Expands

October 29, 2019

Editor's Page

The development of the drug Herceptin (trastuzumab) to treat HER2-positive breast cancer marked an enormous milestone: In the opinion of many, it represented the birth of targeted therapy for cancer.

x